Clinical trial · Observational
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy
Reoperation for Ipsilateral Local Recurrence Following Prior Nephron-sparing Surgery: Innovative Surgical Insights From a High-volume Urological Center
NCT06317207CI-TRIAL-00075170LiangAHcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the safety of reoperation in patients with renal tumors who have ipsilateral tumor recurrence after nephron-sparing partial nephrectomy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
| Robotic Surgical Procedures | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- observation group
- description
- patients who underwent reoperation for locally rRCC after pNSS
Primary outcomes (1)
- measure
- Operation time
- timeFrame
- 1 week
- description
- Operation time
Secondary outcomes (1)
- measure
- Estimated blood loss
- timeFrame
- 1 week
- description
- Estimated blood loss
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1\. ipsilateral local rRCC (any recurrence in the ipsilateral kidney and retroperitoneum) Exclusion Criteria: 1. With distant metastasis; 2. Lacking essential sugery information.
References
Publications (0)
Data not yet available
No reference posted for this study.